Regulation 226 Amendment of regulation 345 (immunity from civil liability)I1F1
United Kingdom
In regulation 345(5), for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation”.
Annotations
Textual amendments
- F1
Reg. 226 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 186
Commencement
- I1
Reg. 226 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1